Please assess the completion status of the following clinical trial:

Trial Title: DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
STUDY INCLUSION CRITERIA- Candidates must meet ALL the following criteria to be enrolled in the DIAMOND-AF study:~1. Above eighteen (18) years of age or of legal age to give informed consent specific to state and national law.~2. Subjects with a history of symptomatic, paroxysmal atrial fibrillation (PAF) who have had ≥2 episodes of PAF reported within the 6 months prior to index ablation procedure with a physician note indicating recurrent, self-terminating AF.~3. At least one episode of PAF documented by electrocardiographic data within the 12 months prior to index ablation procedure.~4. Refractory to at least one Class I-IV AAD for treatment of PAF.~5. Suitable candidate for intra-cardiac mapping and ablation of arrhythmia.~6. Subject agrees to comply with study procedures and be available (geographically stable) for follow-up visits for at least 12 months after enrollment.~7. Subject is willing and able to provide written consent.~STUDY EXCLUSION CRITERIA - Candidates will be excluded from the DIAMOND-AF study if any of the following conditions apply within the following timeframes:~At time of enrollment and/or prior to procedure:~1. AF secondary to electrolyte imbalance, thyroid disease or reversible or non-cardiac cause.~2. LA diameter \> 5.5 cm.~3. LVEF \< 35%.~4. Currently NYHA Class III or IV or exhibits uncontrolled heart failure.~5. BMI \> 40 kg/m2.~6. LA ablation, septal closure device or mitral valve surgical procedure at any time prior to enrollment.~7. Presence of intramural thrombus, tumor or abnormality that precludes vascular access, catheter introduction or manipulation.~8. Coagulopathy, bleeding diathesis or suspected procoagulant state~9. Sepsis, active systemic infection or fever (\>100.5°F / 38°C) within a week prior to the ablation procedure.~10. Significant restrictive or obstructive pulmonary disease or chronic respiratory condition.~11. Renal failure requiring dialysis or renal compromise that in the investigator's judgement would increase risk to the subject or deem the subject inappropriate to participate in the study.~12. Known allergies or intolerance to anticoagulant and antiplatelet therapies to be used in conjunction with the study or contrast sensitivity that cannot be adequately pre-treated prior to the ablation procedure.~13. Positive pregnancy test results for female subjects of childbearing potential or breast feeding.~14. Enrollment in a concurrent clinical study that in the judgement of the investigator would impact study outcomes.~15. Acute or chronic medical condition that in the judgment of the investigator would increase risk to the subject or deem the subject inappropriate to participate in the study.~16. Life expectancy \< 12 months based on medical history or the medical judgement of the investigator.~    Within 1 month of enrollment or just prior to procedure:~17. Documented LA thrombus upon imaging.~18. Creatinine \>2.5mg/dl or creatinine clearance \<30mL/min.~    Within 2 months of enrollment:~19. Regularly (uninterrupted) prescribed amiodarone.~    Within 3 months of enrollment:~20. Significant GI bleed.~21. MI, unstable angina, cardiac surgery or coronary intervention.~    Within 6 months of enrollment:~22. CABG procedure.~23. ICD, CRT leads or pacemaker implant procedure.~24. Documented stroke, CVA, TIA or suspected neurological event.~    Within 12 months of enrollment:~25. An episode of AF lasting \>7 days in duration.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DiamondTemp Ablation Catheter (Type: EXPERIMENTAL): Catheter ablation to treat paroxysmal atrial fibrillation using DiamondTemp temperature-controlled ablation catheter
- TactiCath Quartz Ablation Catheter (Type: ACTIVE_COMPARATOR): Catheter ablation to treat paroxysmal atrial fibrillation using TactiCath Quartz contact-force sensing ablation catheter

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete